- -

Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease

Show full item record

Hernández Teruel, A.; Pérez-Esteve, É.; González-Álvarez, I.; González-Álvarez, M.; Costero Nieto, AM.; Ferri, D.; Gaviña, P.... (2019). Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease. Molecular Pharmaceutics. 16(6):2418-2429. https://doi.org/10.1021/acs.molpharmaceut.9b00041

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/161599

Files in this item

Item Metadata

Title: Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease
Author: Hernández Teruel, Adrián Pérez-Esteve, Édgar González-Álvarez, Isabel González-Álvarez, Marta Costero Nieto, Ana María Ferri, Daniel Gaviña, Pablo Merino Sanjuán, Virginia Martínez-Máñez, Ramón Sancenón Galarza, Félix
UPV Unit: Universitat Politècnica de València. Departamento de Química - Departament de Química
Universitat Politècnica de València. Instituto de Reconocimiento Molecular y Desarrollo Tecnológico - Institut de Reconeixement Molecular i Desenvolupament Tecnològic
Universitat Politècnica de València. Departamento de Tecnología de Alimentos - Departament de Tecnologia d'Aliments
Issued date:
Abstract:
[EN] Silica mesoporous microparticles loaded with both rhodamine B fluorophore (S1) or hydrocortisone (S2), and capped with an olsalazine derivative, are prepared and fully characterized. Suspensions of Si and S2 in water ...[+]
Subjects: Mesoporous silica microparticles , Gated materials , Smart drug delivery materials , Colon targeted release , Inflammatory bowel disease
Copyrigths: Reserva de todos los derechos
Source:
Molecular Pharmaceutics. (issn: 1543-8384 )
DOI: 10.1021/acs.molpharmaceut.9b00041
Publisher:
American Chemical Society
Publisher version: https://doi.org/10.1021/acs.molpharmaceut.9b00041
Project ID:
MICINN/AGL2015-70235-C2-2-R
MINISTERIO DE ECONOMIA Y EMPRESA/MAT2015-64139-C4-1-R
GENERALITAT VALENCIANA/PROMETEO/2018/024
Thanks:
We thank the Generalitat Valenciana (Project PROMETE02018/024) and the Spanish Government (Projects AGL2015-70235-C2-2-R and MAT2015-64139-C4-1-R (MINECO/FEDER)) for support. A.H.T. thanks the Spanish MEC for his FPU ...[+]
Type: Artículo

This item appears in the following Collection(s)

Show full item record